SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is capturing significant community attention as investors rally around its AI-driven infrastructure and potential for long-term utility within the Base ecosystem. Bullish sentiment is being fueled by viral discussions linking the project to high-profile AI developments, prompting active accumulation as holders look toward future growth phases.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending as institutional interest builds around its Ophthalmic platform and the favorable formulary status of VEVYE, leading to strong community conviction that the company is at a historic inflection point. Investors are closely monitoring record prescription growth and sales force expansion as primary catalysts to drive the stock toward long-term targets.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is seeing a surge in investor interest driven by a significant expansion of its NFL live sports content and the broadening of its ad-supported tier to new global markets. Community members are actively debating the timing of share buybacks and whether this recent price action represents a sustainable reversal or merely a temporary relief rally.

Canary XRP ETF - Common Shares of Beneficial Interest

Canary XRP ETF

The XRP ecosystem is experiencing a surge in activity driven by optimism surrounding the CLARITY Act and significant institutional interest in spot ETFs. Investors are actively discussing the potential for increased liquidity, the role of XRP in bridging traditional and digital finance, and the impact of sustained ETF inflows on market supply.

Volatility Shares Trust - Volatility Shares Trust XRP ETF

XRP ETF

The community is heavily focused on XRP following progress with the CLARITY Act, which seeks to clarify the asset's regulatory status as a digital commodity. Investors are actively discussing the potential impact of this legislative momentum, alongside institutional integration news and the growth of XRP-linked exchange-traded products.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending as investors digest the advancement of the CLARITY Act, which seeks to clarify the digital asset's regulatory status, while enthusiasm grows around the increasing institutional adoption fueled by the Bitwise XRP ETF and Ripple's expanding payment infrastructure. Community discussions are heavily focused on navigating current market volatility, analyzing long-term utility for cross-border settlements, and debating the potential impact of legislative developments on future price momentum.

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

The community is actively debating the legitimacy of trending SpaceX-related tickers and crypto tokens, with many users warning that these assets are scams or unauthorized proxies capitalizing on persistent IPO rumors. Investors are expressing a mix of skepticism toward potential rug pulls and excitement over legitimate aerospace sector opportunities, while discussing the impact a future SpaceX public offering could have on the broader market.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

Fetch.ai is experiencing significant momentum as investors rotate capital into decentralized AI infrastructure, driven by institutional partnerships and a broader market focus on autonomous agent technology. The community is actively debating the project's long-term utility against market volatility, with many users focused on identifying accumulation points while weighing the potential for a larger breakout within the AI crypto narrative.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is seeing heightened market volatility and active community debate following multiple FDA rejections of its skin cancer drug, RP1. Investors are intensely focused on recent leadership changes at the agency and conflicting narratives regarding the drug's regulatory path, leading to speculative trading and heated discussions over the company's future viability.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is facing significant downward pressure as investors rotate out of SaaS stocks amid broader concerns that AI agents could disrupt the sector's traditional business models. Despite strong earnings performance and a robust cash position, the community is actively debating whether the recent sell-off is an overreaction to AI-driven fear or a justified repricing due to slowing growth and aggressive competition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum

Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum PR Newswire MORRISTOWN, N.J...

Chasing the Next Explosive Small-Cap Run

Risk appetite came roaring back and several companies standing out, as market participants rotated heavily into sectors tied to transformative technologies and high-growth macro trends. $TGNT, $QUCY, $AEHL, $TDIC, $WGRX, $ERNA, $SLS, $WHWK

Whitehawk Therapeutics Announces $87.5M Private Placement Equity Financing

Whitehawk Therapeutics Announces $87.5M Private Placement Equity Financing Whitehawk Therapeutics Announces $87.5M Private Placement Equity Financing PR Newswire MORRISTOWN, N.J., May 13, 2026...

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Short Interest Update

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) saw a significant growth in short interest in April. As of April 15th, there was short interest totaling 780,056 shares, a growth of 12.4% from the March 31st total of 693,909 shares. Currently, 3.3% of the shares of the stock are sold...

Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026

Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026 Whitehawk Therapeutics Presents Comprehensive Preclinical Data...

Insider Selling: Whitehawk Therapeutics (NASDAQ:WHWK) CFO Sells 77,000 Shares of Stock

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) CFO Scott Giacobello sold 77,000 shares of the business's stock in a transaction that occurred on Wednesday, April 15th. The stock was...

Whitehawk Therapeutics (NASDAQ:WHWK) CFO Scott Giacobello Sells 141,600 Shares

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) CFO Scott Giacobello sold 141,600 shares of Whitehawk Therapeutics stock in a transaction on Thursday, April 16th. The shares were sold at an average price of $4.13, for a total transaction of $584,808.00. Following the completion of the...

Scott Giacobello Sells 77,000 Shares of Whitehawk Therapeutics (NASDAQ:WHWK) Stock

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) CFO Scott Giacobello sold 77,000 shares of the company's stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $3.86, for a total transaction of $297,220.00. Following the completion of the...

Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series

Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series PR Newswire MORRISTOWN...

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Given Consensus Rating of "Hold" by Analysts

Shares of Whitehawk Therapeutics, Inc. (NASDAQ:WHWK - Get Free Report) have been assigned a consensus rating of "Hold" from the five analysts that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three h...

Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.

WHWK
Whitehawk Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest WHWK News

WHWKWhitehawk Therapeutics Inc.